These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2356284)

  • 1. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro.
    Rasey JS; Nelson NJ; Chin L; Evans ML; Grunbaum Z
    Radiat Res; 1990 Jun; 122(3):301-8. PubMed ID: 2356284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
    Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
    J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole.
    Casciari JJ; Rasey JS
    Radiat Res; 1995 Jan; 141(1):28-36. PubMed ID: 7997512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
    Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
    Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
    Rasey JS; Koh WJ; Grierson JR; Grunbaum Z; Krohn KA
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):985-91. PubMed ID: 2808061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of fluoromisonidazole, a new imaging agent for hypoxia.
    Prekeges JL; Rasey JS; Grunbaum Z; Krohn KH
    Biochem Pharmacol; 1991 Nov; 42(12):2387-95. PubMed ID: 1764122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoromisonidazole. A metabolic marker of myocyte hypoxia.
    Martin GV; Cerqueira MD; Caldwell JH; Rasey JS; Embree L; Krohn KA
    Circ Res; 1990 Jul; 67(1):240-4. PubMed ID: 2364494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.
    Martin GV; Caldwell JH; Rasey JS; Grunbaum Z; Cerqueira M; Krohn KA
    J Nucl Med; 1989 Feb; 30(2):194-201. PubMed ID: 2738648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Salvaged' stroke ischaemic penumbra shows significant injury: studies with the hypoxia tracer FMISO.
    Spratt NJ; Donnan GA; McLeod DD; Howells DW
    J Cereb Blood Flow Metab; 2011 Mar; 31(3):934-43. PubMed ID: 20877386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia mediated binding of misonidazole in non-malignant tissue.
    Rasey JS; Hoffman JM; Spence AM; Krohn KA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1255-8. PubMed ID: 3744948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
    Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA
    Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro.
    Franko AJ; Koch CJ; Garrecht BM; Sharplin J; Hughes D
    Cancer Res; 1987 Oct; 47(20):5367-76. PubMed ID: 3652041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
    Roa WH; Chapman JD
    Radiat Res; 1992 Nov; 132(2):248-53. PubMed ID: 1438707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 3H-misonidazole binding between CHO and 9L cells using the sandwich system.
    Hlatky L; Ring C; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):943-7. PubMed ID: 2703402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Barajas RF; Ambady P; Link J; Krohn KA; Raslan A; Mallak N; Woltjer R; Muldoon L; Neuwelt EA
    Neurooncol Pract; 2022 May; 9(3):246-250. PubMed ID: 35601969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
    Huang S; Michalek JE; Reardon DA; Wen PY; Floyd JR; Fox PT; Clarke GD; Jerabek PA; Schmainda KM; Muzi M; Hyun H; Lee EQ; Brenner AJ
    Sci Rep; 2021 Apr; 11(1):7632. PubMed ID: 33828310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research.
    Doctor A; Seifert V; Ullrich M; Hauser S; Pietzsch J
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Hypoxia Imaging Using
    Hirata K; Yamaguchi S; Shiga T; Kuge Y; Tamaki N
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.